Overview
I am a quantitative epidemiologist with methodological expertise in the design and analysis of observational studies that leverage data from cohort studies, registries, and the electronic health record (EHR). My background, training, and research is in the measurement and characterization of biomarkers, risk factors and treatment outcomes for chronic disease using real-world datasets. My primary research interests are in the use of novel sources of data, including the EHR, to conduct chronic disease research at the intersection of informatics, biostatistics, and epidemiology. My ongoing work aims to integrate informatics, epidemiology, and biostatistics to reduce the burden of chronic disease. I have topical expertise in multiple chronic diseases, including oncology, cardiovascular disease, and chronic kidney disease. In parallel, I have a portfolio of research that aims to understand the impact of social determinants of health, including dynamic neighborhood changes, such as gentrification, on the health of adults and children.
Current Appointments & Affiliations
Recent Publications
Off-label use of alemtuzumab, belatacept, and rapamycin in kidney transplantation-Long-term real-world experience.
Journal Article Am J Transplant · January 2026 Conventional immunosuppressive regimens in kidney transplantation continue to pose significant challenges, largely due to their reliance on calcineurin inhibitors (CNIs) and corticosteroids. These challenges have driven the search for alternative regimens ... Full text Link to item CiteNeighborhood Environmental and Contextual Factors Improve Prediction of Childhood Body Mass Index: An Application of Novel Graph Neural Networks.
Journal Article AJE Adv · September 24, 2025 Childhood obesity is a major risk factor for adult cardiovascular disease. Current obesity-prediction models were not developed in diverse populations and do not include heterogeneous social, environmental, and climate factors that may impact body mass ind ... Full text Link to item CiteReal-world quality of life (QOL) in patients (pts) with metastatic renal cell carcinoma (mRCC) on active surveillance (AS) in the ODYSSEY prospective observational study.
Conference Journal of Clinical Oncology · June 2025 4553Background: AS is a recognized strategy in select pts with mRCC to maximize QOL and delay potential toxicity of systemic ... Full text CiteRecent Grants
1/3 CTSA UM1 at Duke University
ResearchFaculty Member · Awarded by National Institutes of Health · 2025 - 2032Sc2i Competitive Renewal
ResearchCo Investigator · Awarded by Henry M. Jackson Foundation · 2021 - 2027Surgical Critical Care Initiative (SC2i): Civilian application of military decision support tools for critically injured patients
ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2023 - 2027View All Grants